glp-1 receptor agonist blood pressure reduction lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 agonists (GLP-1RA) GLP-1 drugs improve liver and
Description
The role of CVO is crucial for sensing peripheral GLP-1 levels and relaying this information to the hypothalamus and other deep brain regions
As GLP-1 therapies gained approval for obesity, prescribing began to diffuse beyond endocrinology into primary care, obesity medicine, and digital health platforms
Whether this translates into protection against the events that matter (kidney failure, dialysis) remains to be tested
2002;282:E873E879
Nausea, diarrhea, and digestive discomfort occur somewhat more frequently with tirzepatide than with semaglutide
& Knop, F
